American International Group Inc. Sells 17,181 Shares of Doximity, Inc. (NASDAQ:DOCS)

American International Group Inc. lowered its stake in Doximity, Inc. (NASDAQ:DOCS) by 9.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 160,076 shares of the company’s stock after selling 17,181 shares during the quarter. American International Group Inc. owned approximately 0.09% of Doximity worth $4,489,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in DOCS. Norges Bank purchased a new stake in shares of Doximity in the 4th quarter valued at about $35,995,000. Vanguard Group Inc. raised its holdings in shares of Doximity by 5.9% in the 3rd quarter. Vanguard Group Inc. now owns 11,038,475 shares of the company’s stock valued at $234,236,000 after acquiring an additional 616,157 shares in the last quarter. Edmond DE Rothschild Holding S.A. raised its holdings in shares of Doximity by 15.1% in the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 2,302,240 shares of the company’s stock valued at $64,555,000 after acquiring an additional 301,290 shares in the last quarter. Pinebridge Investments L.P. purchased a new stake in shares of Doximity in the 4th quarter valued at about $2,845,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Doximity by 10.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 699,066 shares of the company’s stock valued at $14,834,000 after acquiring an additional 67,363 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

DOCS opened at $27.52 on Friday. The stock’s 50 day simple moving average is $26.37 and its 200 day simple moving average is $27.31. Doximity, Inc. has a 1 year low of $19.71 and a 1 year high of $36.29. The firm has a market cap of $5.10 billion, a price-to-earnings ratio of 38.22, a PEG ratio of 5.08 and a beta of 1.23.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings results on Thursday, May 16th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.04. The business had revenue of $118.06 million for the quarter, compared to analyst estimates of $116.46 million. Doximity had a return on equity of 17.44% and a net margin of 31.04%. As a group, sell-side analysts anticipate that Doximity, Inc. will post 0.74 EPS for the current year.

Insider Transactions at Doximity

In other news, insider Craig Overpeck sold 1,500 shares of Doximity stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $23.85, for a total value of $35,775.00. Following the sale, the insider now directly owns 108,609 shares in the company, valued at approximately $2,590,324.65. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, insider Craig Overpeck sold 1,500 shares of Doximity stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $23.85, for a total value of $35,775.00. Following the sale, the insider now directly owns 108,609 shares in the company, valued at approximately $2,590,324.65. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $30.00, for a total value of $900,000.00. Following the completion of the sale, the chief financial officer now owns 288,685 shares in the company, valued at $8,660,550. The disclosure for this sale can be found here. In the last three months, insiders have sold 46,500 shares of company stock worth $1,371,250. 39.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

DOCS has been the topic of several recent analyst reports. Morgan Stanley reaffirmed an “underweight” rating and issued a $25.00 price target on shares of Doximity in a report on Tuesday, April 23rd. JPMorgan Chase & Co. raised Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price objective on the stock in a report on Thursday, April 25th. William Blair reissued an “outperform” rating on shares of Doximity in a report on Friday, May 17th. Leerink Partnrs reissued a “market perform” rating on shares of Doximity in a report on Monday, February 26th. Finally, SVB Leerink began coverage on Doximity in a report on Monday, February 26th. They set a “market perform” rating and a $32.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Doximity currently has a consensus rating of “Hold” and an average target price of $28.73.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.